ALTUVIIIO
Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl · KIT · Bioverativ Therapeutics Inc.
ALTUVIIIO is a kit containing antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl. Manufactured by Bioverativ Therapeutics Inc..
Key Facts
- Brand Name
- ALTUVIIIO
- Generic Name
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl
- NDC Code (Product)
71104-979- Manufacturer
- Bioverativ Therapeutics Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125771
- Marketing Start
- 02/22/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ALTUVIIIO used for?
ALTUVIIIO contains Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. It is a kit taken as directed. Consult your doctor for specific uses.
Is ALTUVIIIO a controlled substance?
ALTUVIIIO is not classified as a controlled substance by the DEA.
What is the generic name for ALTUVIIIO?
The generic name for ALTUVIIIO is Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. There are no other listed brand versions of Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl.
What is the NDC code for ALTUVIIIO ?
The NDC (National Drug Code) for ALTUVIIIO is 71104-979, listed by Bioverativ Therapeutics Inc..
Other ALTUVIIIO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)